|1.||Li, Xiaoling: 3 articles (05/2007 - 05/2005)|
|2.||Choudhry, Mashkoor A: 3 articles (05/2007 - 05/2005)|
|3.||Chaudry, Irshad H: 3 articles (05/2007 - 05/2005)|
|4.||Sozen, Takumi: 2 articles (03/2010 - 12/2009)|
|5.||Chen, Wanqiu: 2 articles (03/2010 - 12/2009)|
|6.||Schwacha, Martin G: 2 articles (05/2007 - 08/2006)|
|7.||Rana, Shadab N: 2 articles (08/2006 - 05/2005)|
|8.||Li, Heng: 1 article (01/2015)|
|9.||Duan, Ruo-Nan: 1 article (01/2015)|
|10.||Zhang, Peng: 1 article (01/2015)|
|1.||Experimental Autoimmune Myasthenia Gravis (Autoimmune Experimental Myasthenia Gravis)
01/01/2015 - "Caspase-1 inhibitor ameliorates experimental autoimmune myasthenia gravis by innate dendric cell IL-1-IL-17 pathway."
01/01/2015 - "Our results suggest that caspase-1 inhibitor ameliorates experimental autoimmune myasthenia gravis by innate DC IL-1-IL-17 pathway and provides new evidence that caspase-1 is an important drug target in the treatment of MG and other autoimmune diseases."
01/01/2015 - "To investigate the effects of caspase-1 inhibitor on experimental autoimmune myasthenia gravis (EAMG), an animal model of MG, caspase-1 inhibitor was administered to Lewis rats immunized with region 97-116 of the rat AChR α subunit (R97-116 peptide) in complete Freund's adjuvant. "
|2.||Autoimmune Diseases (Autoimmune Disease)
01/01/2003 - "8. This study demonstrates that injection of a selective caspase-1 inhibitor after myocardial ischaemia markedly reduced the detrimental effect conferred by hypercholesterolaemia on myocardial ischaemia-reperfusion injury by attenuating both necrotic as well as apoptotic cell death pathways through inhibition of IL-1beta production and activation of caspase-1 and caspase-3."
08/01/2006 - "Treatment of rats with CORT inhibitor or with caspase-1 inhibitor prevented the increase in all of the above parameters following a combined insult of EtOH and burn injury. "
01/01/2012 - "Lastly, the functional significance of inflammasome activation following burn injury was tested in mice treated with the specific caspase-1 inhibitor, AC-YVAD-CMK. "
05/01/2005 - "Treatment of rats with caspase-1 inhibitor significantly attenuated the increase in IL-18 levels and intestinal MPO activity in EtOH and burn-injured rats. "
05/01/2007 - "Treatment of rats with caspase-1 inhibitor prevented the increase in lung tissue IL-18, CINC-1, CINC-3, ICAM-1, MPO activity, and edema following EtOH and burn injury. "
|1.||N-acetyl-tyrosyl-valyl-alanyl-aspartyl chloromethyl ketone
|2.||Caspase 3 (Caspase-3)
|3.||Interleukin-18 (Interleukin 18)
|4.||Interleukin-10 (Interleukin 10)
|5.||NF-kappa B (NF-kB)
|7.||Interleukin-1 (Interleukin 1)
|8.||Myeloid Differentiation Factor 88
|9.||Interleukin-17 (Interleukin 27)
|10.||Caspase 1 (ICE Protease)